Jane Street’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAB
ACA
SCM
HF
Jane Street's BCAB Position: Q2 2026 in Review
Jane Street sold out of BioAtla (BCAB) in Q2 2026, closing a stake of 463 shares — an estimated $3.73K sold.
Jane Street first reported a position in BCAB in Q1 2021 and held it in 17 quarters. The position peaked at $461K in Q4 2022. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.
- Jane Street reported no remaining BioAtla position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 463 BioAtla shares in Q2 2026, an estimated $3.73K.
- Jane Street first reported a position in BioAtla in Q1 2021 and held it in 17 quarters.
- Jane Street's BioAtla position peaked at $461K in Q4 2022.
- 21 funds tracked by Wall St. Rank held BioAtla as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.